Treatment of Pneumonia Unresponsive to Levofloxacin
Assessment of Treatment Failure
- When a patient fails to respond to initial levofloxacin therapy, conduct a thorough review by an experienced clinician of the clinical history, examination, prescription chart, and results of all available investigations, as recommended by the British Thoracic Society 1
- Consider additional investigations including repeat chest radiograph, CRP and white cell count, and further specimens for microbiological testing, according to the British Thoracic Society guidelines 1
- Review microbiological data to exclude Staphylococcus aureus and Gram-negative bacillary infection, as suggested by the Journal of Infection 4
- Verify compliance with and adequate absorption of the oral regimen if applicable, as recommended by the Journal of Infection 4
Alternative Antibiotic Options
- Change to a combination of a beta-lactam (co-amoxiclav, cefuroxime, cefotaxime, or ceftriaxone) plus a macrolide (clarithromycin or erythromycin) for non-severe pneumonia, as recommended by the British Thoracic Society 1
- If the patient has a beta-lactam allergy, consider clindamycin as an alternative, according to the American Journal of Respiratory and Critical Care Medicine 6
- For severe pneumonia, add coverage for MRSA if suspected, as suggested by the Journal of Infection 4
- Consider an antipseudomonal agent (piperacillin-tazobactam, cefepime, meropenem) if Pseudomonas aeruginosa is a concern, particularly in patients with risk factors, as recommended by Clinical Infectious Diseases 7
Considerations for Specific Pathogens
- If DRSP (drug-resistant Streptococcus pneumoniae) is suspected, consider using a newer fluoroquinolone with better pneumococcal coverage (moxifloxacin, gatifloxacin) or vancomycin, according to the American Journal of Respiratory and Critical Care Medicine 6
- For pneumococcal MIC values to penicillin at 4 mg/L or greater, therapy should be with a newer antipneumococcal fluoroquinolone, vancomycin, or clindamycin, as recommended by the American Journal of Respiratory and Critical Care Medicine 6
- If staphylococcal pneumonia is suspected, add flucloxacillin (for MSSA) or vancomycin (for MRSA), as suggested by the Journal of Infection 4
Route of Administration and Duration
- For patients requiring hospitalization, use parenteral antibiotics initially, as recommended by the British Thoracic Society 1
- Transfer to oral therapy when clinical improvement occurs and temperature has been normal for 24 hours, providing there is no contraindication to the oral route, according to the British Thoracic Society guidelines 1
- For severe, microbiologically undefined pneumonia, 10 days of treatment is recommended, as suggested by the British Thoracic Society 1
- Extended treatment (14-21 days) is recommended when legionella, staphylococcal, or Gram-negative enteric bacilli pneumonia are suspected or confirmed, according to the British Thoracic Society guidelines 1
Common Pitfalls and Caveats
- Delaying appropriate antibiotic therapy can increase mortality, so prompt reassessment and change of antibiotics is essential when treatment failure is suspected, as recommended by Clinical Infectious Diseases 8
- Vancomycin should have a limited role and be reserved for patients with high-level resistance who are failing other therapies, according to the American Journal of Respiratory and Critical Care Medicine 6
Monitoring Response to New Treatment
- Monitor clinical response daily, including temperature, respiratory and hemodynamic parameters, as recommended by the American College of Chest Physicians is not mentioned, however, the Praxis Medical Insights: Practical Summaries of Clinical Guidelines is mentioned 3
- Consider measuring C-reactive protein on days one and three/four, especially in patients with unfavorable clinical parameters, according to the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2
- Arrange clinical review for all patients at around 6 weeks, with a chest radiograph for those with persistent symptoms or physical signs, as suggested by the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 5